Fluidigm Corporation (FLDM)
Last closing price (Apr 17 4:00 EDT):
37.10 (2.06%) ?
Fluidigm Corporation develops, manufactures, and markets microfluidic systems for academic research institutions, clinical laboratories, pharmaceutical companies, and biotechnology and Ag-Bio companies. Its proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits (IFCs), assays, and other reagents. The companys products include BioMark HD system that performs high-throughput gene expression analysis, single-cell gene expression analysis, single nucleotide polymorphism (SNP) genotyping, and digital polymerase chain reaction (PCR) using Fluidigm DELTAgene and SNPtype assays, other chemistries, and Fluidigm dynamic array and digital array IFCs; and EP1 system that performs SNP genotyping using Fluidigm SNPtype assays or TagMan assays, as well as end-point digital PCR using TaqMan assays, and Fluidigm Dynamic Array and Digital Array IFCs. Its products also comprise C1 Single-Cell Auto Prep system, which enables rapid and reliable isolation, processing, and profiling of individual cells for genomic analysis for various applications, such as targeted single-cell gene expression and single-cell messenger ribonucleic acids analysis; and Access Array system that enables automated sample preparation, barcoding, and tagging of targeted resequencing libraries. In addition, the company offers dynamic array, digital array, C1 single-cell auto prep array, and access array IFCs; and DELTAgene and SNPtype assays, and access array target-specific primers. Fluidigm Corporation distributes its systems through direct sales force and support organizations in North America, Europe, and the Asia-Pacific; and through distributors or sales agents in Europe, Latin America, the Middle East, and the Asia-Pacific countries. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
|Dan Leonard||Leerink Swann Llc||Buy||Apr 14, '14||35.27||Apr 14, '15||5.19%|
|Jonathan Chen||Unaffiliated||Buy||Mar 17, '14||47.87||55.00||Mar 17, '15||-22.50%|
|David Ferreiro||Oppenheimer & Co.||Buy||Feb 03, '14||43.60||52.00||Feb 03, '15||-14.91%|
|Doug Schenkel||Cowen And Company||Buy||Aug 12, '13||20.13||24.00||Aug 12, '14||84.30%|
|Sung Ji Nam||Cantor Fitzgerald||Buy||Aug 02, '13||19.55||23.00||Aug 02, '14||89.77%|
|Sung Ji Nam||Cantor Fitzgerald||Buy||Feb 12, '13||16.69||20.00||Feb 12, '14||154.22%|
|Peter Lawson||Mizuho Securities USA||Buy||Oct 08, '12||16.35||17.00||Oct 08, '13||33.94%|
|David Ferreiro||Oppenheimer & Co.||Buy||Sep 11, '12||15.69||Sep 11, '13||38.37%|
|Peter Lawson||Mizuho Securities USA||Buy||Aug 30, '12||15.28||17.00||Aug 30, '13||33.84%|
|Sung Ji Nam||Cantor Fitzgerald||Buy||Jun 25, '12||14.72||17.00||Jun 25, '13||15.49%|
|David Ferreiro||Oppenheimer & Co.||Buy||May 10, '12||14.65||19.00||May 10, '13||29.69%|
|David Ferreiro||Oppenheimer & Co.||Buy||Nov 08, '11||13.65||19.00||Nov 08, '12||6.59%|
|David Ferreiro||Oppenheimer & Co.||Buy||Oct 04, '11||14.32||19.00||Oct 04, '12||17.32%|